Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
for Renal Cell Carcinoma (RCC)
44 locations incl. Phoenix
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022
Exelixis Clinical
Clinical research site in Myrtle Beach, South Carolina · 917 BROADWAY ST STE 3, MYRTLE BEACH, SC 29577-3718 · (843) 582-7887
Part of Exelixis Clinical
As of July 2026, 1 paid clinical trial is recruiting at Exelixis Clinical in Myrtle Beach, South Carolina. Active studies at this site cover conditions such as Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer (CRC) and Head and Neck Squamous Cell Carcinoma (HNSCC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Exelixis Clinical (1)
More research sites in Myrtle Beach
- Carolina Urologic Research Center (32 trials)
- Carolina Urologic Research Center, LLC (12 trials)
- Parkway Surgery Center (6 trials)
- Grand Strand Medical Center (5 trials)
- Trial Management Associates (3 trials)
- AUC Urologists, LLC (2 trials)
- Carolina Regional Cancer Center (2 trials)
- AMR Clinical South Strand, South Carolina (1 trial)
- Atlantic Urology Specialists (1 trial)
- Avenzo Therapeutics Recruiting Site (1 trial)
Explore more
Paid clinical trials in Myrtle Beach, SC · South Carolina clinical trials